ENB003

· ENB Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ENB003, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors [Phase 1, Phase 2]